placeholder image
A. B. Payne All authors
About
Publications While At HealthPartners
Highlights
selected publications
Journal Article
  • 18 years - VISION and IVY Networks, September 2024-January 2025. 
    MMWR: Morbidity and Mortality Weekly Report. 2025
  • Effectiveness of 2023-2024 seasonal influenza vaccine against influenza-associated emergency department and urgent care encounters among pregnant and non-pregnant women of reproductive age. 
    Vaccine. 2025
  • Effectiveness of nirsevimab among infants in their first RSV season in the United States, October 2023-March 2024: a test-negative design analysis. 
    Lancet Reg Health Am. 2025
  • Estimated 2023-2024 COVID-19 vaccine effectiveness in adults. 
    JAMA network open. 2025
  • Influenza vaccine effectiveness against hospitalizations and emergency department or urgent care encounters for children, adolescents, and adults during the 2023-2024 season, United States. 
    Clinical Infectious Diseases. 2025
  • Interim estimates of 2024-2025 seasonal influenza vaccine effectiveness - four vaccine effectiveness networks, United States, October 2024-February 2025. 
    MMWR: Morbidity and Mortality Weekly Report. 2025
  • 18 Years - VISION and IVY Networks, September 2023-January 2024. 
    MMWR: Morbidity and Mortality Weekly Report. 2024
  • 18 years with immunocompromising conditions - VISION Network, September 2023-February 2024. 
    MMWR: Morbidity and Mortality Weekly Report. 2024
  • Interim estimates of 2023-24 seasonal influenza vaccine effectiveness - United States. 
    MMWR: Morbidity and Mortality Weekly Report. 2024
  • Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis. 
    Lancet (London, England). 2024
  • Estimates of bivalent mRNA vaccine durability in preventing COVID-19-associated hospitalization and critical illness among adults with and without immunocompromising conditions - VISION Network, September 2022-April 2023. 
    American Journal of Transplantation. 2023
  • Estimates of bivalent mRNA vaccine durability in preventing COVID-19-associated hospitalization and critical illness among adults with and without immunocompromising conditions - VISION Network, September 2022-April 2023. 
    MMWR: Morbidity and Mortality Weekly Report. 2023
  • Impact of accounting for correlation between COVID-19 and influenza vaccination in a COVID-19 vaccine effectiveness evaluation using a test-negative design. 
    Vaccine. 2023
    • Contact
    full name
  • A. B. Payne
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.
    Collaboration